Ellen C. Kenney represents prominent national and international companies in the utilities, technology, pharmaceutical, and health and beauty industries in California state courts and federal courts nationwide. She has extensive experience with intellectual property litigation, including patent and trade secrets cases, as well as employment-related matters, class action defense, and mass tort defense.
Ms. Kenney has been a member of several trial and arbitration teams and participated in a multi-week trial in federal district court in Seattle. In addition to trials, Ms. Kenney has experience in all stages of litigation, with a particular focus on e-discovery and discovery disputes. Her notable clients include Bausch Health Companies Inc., T-Mobile, CoreLogic, and Southern California Edison Company.
While in law school, Ms. Kenney worked as a judicial extern for the Honorable George Wu of the U.S. District Court for the Central District of California. She also externed for the Civil Division of the U.S. Attorney’s office in Los Angeles.
Secured a favorable settlement for CoreLogic Solutions LLC—one of the country’s leading property information, analytics, and services providers—in a trade secrets and breach of contract case against former employees. The settlement included permanent injunctions and admissions from all defendants that they improperly took confidential information when leaving to work for a competitor.
Representing a prominent telecommunications carrier in a trade secrets case against a Chinese cellphone manufacturer.
Represented Western Digital and its SanDisk subsidiaries in their widely publicized dispute with Toshiba over anti-transfer provisions in joint venture agreements governing the manufacture and development of NAND flash memory. The dispute encompassed multiple international arbitrations and litigation in the California trial and appellate courts, where SanDisk secured injunctive relief in aid of the arbitrations.
Represented a premier medical treatment company in a patent trial involving an innovative device for treating glaucoma. The matter settled on the eve of trial.
Ruhnke v. Allergan. On behalf of client Allergan, obtained a low five-figure settlement in a putative consumer class action litigation seeking over $85 million in damages. The settlement came on the eve of plaintiffs’ certification papers being due and following aggressive offensive discovery that revealed facts damaging to plaintiffs’ case. The suit alleged that Allergan’s leading skincare and cosmetics line is in violation of the Food, Drug, and Cosmetic Act, and that the product was being marketed in a way that violates false advertising and unfair competition laws.
Defended Valeant Pharmaceuticals in a multibillion-dollar securities class action, alleging violation of insider trading and control person liability statutes. After argument on summary judgment motions, obtained favorable settlements on all matters.